文献速递甲状腺与颈部外科

1至4厘米甲状腺乳头状癌切缘阳性与生存结局:14,471例回顾分析

Margin Positivity and Survival Outcomes: A Review of 14,471 Patients with 1-cm to 4-cm Papillary Thyroid Carcinoma.
PubMed 文献 · J Am Coll Surg · 2021-01-07

基于美国国家癌症数据库2004至2016年14,471例1至4厘米甲状腺乳头状癌行甲状腺切除术患者,分析切缘状态、切除范围、手术量和机构类型对生存的影响。 microscopic切缘阳性者占15.3%,与较低生存相关(HR 1.464,p<0.05)。较高手术量(OR 0.979,p<0.01)和学术中心手术(OR 0.623,p<0.001)与较低切缘阳性率相关。

要点

  • 1至4厘米PTC中显微镜下切缘阳性率15.3%,与较低生存独立相关(HR 1.464)。
  • 较高手术量(OR 0.979)和学术中心手术(OR 0.623)与较低切缘阳性几率相关。
  • 切缘阳性为可改变风险因素,具侵袭特征者转诊至高流量学术中心或改善生存。

核心结论

  • 在1至4厘米甲状腺乳头状癌患者中,显微镜下切缘阳性与较低生存相关(HR 1.464,p<0.05)。
  • 较高手术量(OR 0.979,p<0.01)和学术中心手术(OR 0.623,p<0.001)与较低切缘阳性几率相关。
  • 切缘阳性为可改变风险因素,具侵袭特征患者转诊至高流量学术中心可能改善生存。

研究设计与样本

  • 回顾性队列研究,使用美国国家癌症数据库(NCDB)2004至2016年数据。
  • 纳入14,471例1至4厘米甲状腺乳头状癌行甲状腺切除术患者。
  • 采用Kaplan-Meier法和log rank检验估计生存,Cox比例风险模型和二元logistic回归分析生存及切缘阳性的影响因素。

主要发现

  • 14,471例中,2,269例(15.7%)存在淋巴血管侵犯,6,925例(47.9%)为多灶性,14,235例(98.3%)行全甲状腺切除术。
  • 2,212例(15.3%)存在显微镜下切缘阳性,其生存较低(HR 1.464,p<0.05)。
  • 30天和90天死亡率分别为0.1%和0.2%。
  • 手术量(OR 0.979,p<0.01)和学术中心甲状腺手术(OR 0.623,p<0.001)与较低切缘阳性几率相关。

临床怎么用

  • 对于1至4厘米甲状腺乳头状癌,应关注切缘状态,显微镜下切缘阳性与较低生存相关。
  • 具侵袭特征的患者可考虑转诊至高手术量学术中心以降低切缘阳性风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Papillary thyroid carcinoma (PTC) comprises the majority of thyroid malignancy, but it is associated with excellent long-term survival. Highly prevalent, with increasing incidence, the optimal operative management for patients with 1- to 4-cm PTC remains unclear. This study determined factors that affect clinical outcomes, including survival, in this patient population. STUDY DESIGN: Patients with 1- to 4-cm PTC, who underwent thyroidectomy between 2004 and 2016, were identified in the National Cancer Database (NCDB). Factors affecting survival, including margin status, extent of resection, operative volume, and institution type, were studied. Outcomes were estimated by Kaplan-Meier and log rank tests. Cox proportional hazard and binary logistic regression analyses identified factors affecting survival as well as margin positivity. RESULTS: Of 14,471 patients with 1- to 4-cm PTC, 2,269 (15.7%) exhibited lymphovascular invasion, 6,925 (47.9%) had multifocality, 14,235 (98.3%) underwent total thyroidectomy, and 2,212 (15.3%) had microscopic margin positivity, which conferred lower survival (hazard ratio [HR] 1.464, p < 0.05), with 30-day and 90-day mortality of 0.1% and 0.2%, respectively. Operative volume (odds ratio [OR] 0.979, p < 0.01) and thyroid surgery at an academic center (OR 0.623, p < 0.001) were associated with lower odds of margin positivity. CONCLUSIONS: In patients with 1- to 4-cm PTC, margin positivity confers lower survival. Factors associated with lower rate of margin positivity are higher operative volume and referral for treatment at academic center. Because margin positivity is a modifiable risk factor, referral of patients with aggressive features of PTC to high volume academic centers may improve survival.

来源:J Am Coll Surg,查看原文。版权归原作者所有。

引用

  1. Khan ZF, Kutlu O, Picado O, et al. Margin Positivity and Survival Outcomes: A Review of 14,471 Patients with 1-cm to 4-cm Papillary Thyroid Carcinoma. J Am Coll Surg. 2021. PMID: 33421566. doi:10.1016/j.jamcollsurg.2020.12.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。